Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Johnson & Johnson
(NY:
JNJ
)
239.24
-0.69 (-0.29%)
Official Closing Price
Updated: 7:00 PM EDT, Mar 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,171,289
Open
240.00
Bid (Size)
239.00 (100)
Ask (Size)
240.10 (100)
Prev. Close
239.93
Today's Range
238.93 - 241.65
52wk Range
141.50 - 251.71
Shares Outstanding
2,628,679,824
Dividend Yield
2.17%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
A Q2 2026 Playbook for Navigating Market Uncertainty
↗
Today 16:07 EDT
Via
MarketBeat
What You Need To Know Ahead of Johnson & Johnson's Earnings Release
Today 10:18 EDT
Johnson & Johnson is expected to announce its first-quarter results next month, and analysts are projecting a single-digit decline in its EPS.
Via
Barchart.com
Topics
ETFs
Performance
YTD
+15.4%
+15.4%
1 Month
-2.7%
-2.7%
3 Month
+15.1%
+15.1%
6 Month
+35.4%
+35.4%
1 Year
+48.6%
+48.6%
More News
Read More
The 15-Minute Breakthrough: A Deep Dive into GH Research (GHRS) and the Future of Rapid-Acting Psychedelics
Today 10:09 EDT
Via
Finterra
Topics
Cannabis
Initial Public Offering
Intellectual Property
Johnson & Johnson (JNJ) Forecast: Extended Rally Signals Patience for Buyers
↗
March 17, 2026
Via
Talk Markets
The Fear Gauge Ascendant: VIX Hits 26 as Geopolitical Storms and 'Higher-for-Longer' Reality Grip Markets
March 24, 2026
Via
MarketMinute
Topics
Derivatives
Economy
Stocks
If You Only Own Tech Stocks, Jim Cramer Has a Blunt Warning for You in 2026
↗
March 23, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
Stocks
FDA Approves Protagonist’s ICOTYDE: The Oral Peptide Revolution Hits the Psoriasis Market
March 23, 2026
Via
MarketMinute
1 Dividend ETF That Could Turn $500 Monthly Into a $725,000 Portfolio That Pays $21,750 Annually
↗
March 20, 2026
Via
The Motley Fool
Topics
ETFs
Johnson & Johnson-Protagonist Therapeutics Partnered New Psoriasis Pill Wins FDA Nod, Shakes Up Competition With AbbVie
↗
March 19, 2026
Via
Benzinga
2 Reasons to Buy Johnson & Johnson Stock Like There's No Tomorrow
↗
March 19, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
AbbVie Shares Retreat to Multi-Month Lows Amid Competitive Headwinds and Technical Breakdown
March 18, 2026
Via
MarketMinute
Topics
ETFs
Economy
Intellectual Property
The High-Stakes Gambit: How Healthcare Giants are 'Front-Loading' Megadeals to Outrun Regulatory Storms
March 18, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Intellectual Property
2 Stocks That Could Create Lasting Generational Wealth
↗
March 17, 2026
Via
The Motley Fool
Topics
World Trade
The $40 Billion Pivot: Kimberly-Clark and Kenvue Merger Redefines the Consumer Staples Landscape
March 16, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Lawsuit
Your Tax Refund Will Probably Be Bigger This Year. Here's What to Do With It.
↗
March 16, 2026
Via
The Motley Fool
Topics
Economy
Retirement
Stryker Corporation (SYK): Navigating Innovation and Resilience in the Wake of a Digital Crisis
March 16, 2026
Via
Finterra
Topics
Earnings
Economy
Hacking
Johnson & Johnson’s Trial In Early-Stage Bladder Cancer Yield Positive Safety Results
↗
March 13, 2026
Via
Stocktwits
Flight to Quality: JPMorgan and Eli Lilly Emerge as Defensive Anchors Amid Geopolitical Storm
March 13, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
The Best Dividend Stocks to Buy and Hold Forever
↗
March 12, 2026
Via
The Motley Fool
Topics
Intellectual Property
1 No-Brainer S&P 500 Vanguard ETF to Buy Right Now for Less Than $1,000
↗
March 12, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
Economy
The Azetukalner Breakthrough: A Deep Dive into Xenon Pharmaceuticals (XENE)
March 12, 2026
Via
Finterra
Topics
ETFs
Intellectual Property
Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients
March 12, 2026
From
Johnson & Johnson
Via
Business Wire
End of an Era: West Pharmaceutical Shares Slide as Longtime CEO Eric Green Announces Retirement
March 11, 2026
Via
MarketMinute
Topics
Economy
Retirement
Cracks in the Bull Case: S&P 500 Breaches Key Support as Institutional Distribution Takes Hold
March 11, 2026
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
Safe Haven in a Storm: Healthcare Leads Markets as Geopolitical Tensions Spark Defensive Rotation
March 10, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
Frequently Asked Questions
Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 239.24
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 03/26/26 07:00 PM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 628.89B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 629B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.